Oramed Pharmaceuticals
ORMP
#9035
Rank
A$0.14 B
Marketcap
$3.49
Share price
-3.86%
Change (1 day)
-6.43%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): -A$0.35 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of A$11.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 A$0.55 M-95.05%
2023 A$11.1 M-119.45%
2022 -A$57.08 Million39.17%
2021 -A$41.01 Million73.93%
2020 -A$23.58 Million18.53%
2019 -A$19.9 Million-16.62%
2018 -A$23.86 Million38.32%
2017 -A$17.25 Million12.51%
2016 -A$15.33 Million25.01%
2015 -A$12.27 Million18.18%
2014 -A$10.38 Million39.72%
2013 -A$7.43 Million46.4%
2012 -A$5.08 Million128.32%
2011 -A$2.23 Million-51.47%
2010 -A$4.58 Million35.21%
2009 -A$3.39 Million
2007 -A$5.33 Million607.04%
2006 -A$0.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.79 Billion-143,030.59%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.51 B 5,365,367.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
A$13.68 B 2,487,273.94%๐Ÿ‡ซ๐Ÿ‡ท France
-A$15.13 Million-2,850.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$0.32 Billion-56,871.39%๐Ÿ‡บ๐Ÿ‡ธ USA